Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Stargardt disease
Stargardt disease
FDA Clears Ascidian for First-Ever RNA Editing Trial in US
BioSpace
Tue, 01/30/24 - 09:22 pm
Ascidian Therapeutics
FDA
clinical trials
Stargardt disease
RNA editing
Alkeus raises funds to launch Stargardt disease therapy gildeuretinol
Pharmaceutical Technology
Wed, 06/7/23 - 10:09 am
Alkeus Pharmaceuticals
funding
gildeuretinol
Stargardt disease
blindness
Alnylam scraps trial in rare eye disorder, blaming drug price reforms
Pharmaphorum
Fri, 10/28/22 - 10:25 am
Alnylam
RNAi
vutrisiran
Stargardt disease
Inflation Reduction Act
drug pricing
Sea creature-inspired biotech Ascidian surfaces with $50M and a new way to edit RNA
MedCity News
Wed, 10/12/22 - 10:32 am
Ascidian Therapeutics
RNA
Stargardt disease
funding
Ophthotech Completes Recruitment for Ph IIb Trial of Zimura for Geographic Atrophy Secondary to Dry AMD
CP Wire
Thu, 10/4/18 - 09:36 am
Opthotech
Zimura
wet age-related macular degeneration
dry age-related macular degeneration
Stargardt disease
Ophthotech Completes Recruitment for Ph IIb Trial of Zimura for Geographic Atrophy Secondary to Dry AMD
Thu, 10/4/18 - 12:45 pm
Opthotech
Zimura
wet age-related macular degeneration
dry age-related macular degeneration
Stargardt disease
